Venus-Vitae Pivotal Study Smart-Align Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.
Also called NCT05991271
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Venus MedTech (HangZhou) Inc.
- Registry
-
NCT05991271
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05991271. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-31 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Venus-Vitae Pivotal Study Smart-Align Study
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- Venus-Vitae Transcatheter Heart Valve System
- Lead sponsor
- Venus MedTech (HangZhou) Inc.
Record details
- Record id
cardio:ct-nct05991271- Content hash
67d9e02d66cdb39c35e8bf4205f7fc04c27baadea5c2900f310ee1e141830e1f